Current Opinion in Pharmacology

Papers
(The median citation count of Current Opinion in Pharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology88
Editorial Board79
Editorial overview: Immune regulation and cancers73
Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics57
Editorial Board57
Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence55
Editorial overview – 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies43
Editorial Board42
Editorial Board41
Lipid raft disruption as an opportunity for peripheral analgesia41
Editorial Board36
Non-alcoholic fatty liver disease: Current therapeutic options33
MicroRNA: A mediator of diet-induced cardiovascular protection32
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling32
Tropical fruits from Australia as potential treatments for metabolic syndrome31
Dietary serine supplementation: Friend or foe?31
Splice-switching as cancer therapy30
Elexacaftor–tezacaftor–ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation30
Stress, kisspeptin, and functional hypothalamic amenorrhea29
Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer29
Pharmacologic treatment of gastroparesis: What is (still) on the horizon?29
New CARs on and off the road: challenges and new developments in CAR-T cell therapy28
Quantitative assessment of volumetric muscle loss: Dual-energy X-ray absorptiometry and ultrasonography28
Organotypic human ex vivo models for coronavirus disease 2019 research and drug development28
Host membrane proteins in the HIV-induced membrane fusion: Role in pathogenesis and therapeutic potential of autoantibodies27
Current pharmacological treatment of hepatocellular carcinoma27
Nutraceuticals use and type 2 diabetes mellitus25
Metabolic regulation of tissue-resident memory CD8+ T cells25
Interrogating the function of GABAA receptors in the brain with optogenetic pharmacology25
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?24
Estrogen related receptor alpha: Potential modulator of age-related macular degeneration24
Nutraceuticals in mental diseases — Bridging the gap between traditional use and modern pharmacology23
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies22
Editorial overview: “Purinergic immune cell regulation reveals novel pharmacological targets”21
Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain21
Drug effects on neuropeptides and their receptors: Big hopes but moderate success in the treatment of chronic pain21
Recent advances in emerging PCOS therapies21
Balancing Genome Integrity and Carcinogenesis: Insights into DNA Damage Response, Repair Pathways, and Cancer Therapies21
Emerging drugs for the treatment of primary sclerosing cholangitis21
Circulating factors that influence the central nervous system remyelination21
Photopharmacological control of cell signaling with photoswitchable lipids20
The active kinome: The modern view of how active protein kinase networks fit in biological research20
Corrigendum to ‘JAK inhibitors: Current position in treatment strategies for use in inflammatory bowel disease’20
Beyond the AMPA receptor: Diverse roles of SynDIG/PRRT brain-specific transmembrane proteins at excitatory synapses19
Integrating network pharmacology: The next-generation approach in ocular drug discovery19
Photoswitchable allosteric modulators for metabotropic glutamate receptors19
The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms19
The 2013–2016 Ebola virus disease outbreak in West Africa19
Disease-modifying therapies in short bowel syndrome18
Novel strategies to promote resolution of inflammation to treat lower extremity artery disease18
Interventional functional diagnostics in gastrointestinal endoscopy: Combining diagnostic and therapeutic tools in the endoscopy suite with the functional lumen imaging probe18
Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers18
New developments in treatments for systemic vasculitis18
The role of extracellular ATP in homeostatic immune cell migration18
Impact of amino acids on microglial activation and CNS remyelination18
Editorial Board17
Editorial Board17
The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids17
Editorial overview: COVID-19 therapy: From lung disease to systemic disorder17
Current status of hepatitis delta17
Editorial overview: Endocrine and metabolic diseases (2023)16
Editorial Board16
Cancer 2021: New therapeutic approaches for the treatment of cancer — building on advances in cancer biology and the molecular genetics of cancer16
Gastrointestinal issue: Advances in gastrointestinal oncology16
Editorial overview: Neuroscience: Advances in the field15
Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction15
Editorial Board15
Artemisinins and their impact on inhibitory neurotransmission15
Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?15
Targeting intramuscular adipose tissue expansion to preserve contractile function in volumetric muscle loss: A potentially novel therapy?15
Optofluidic neural interfaces for in vivo photopharmacology15
The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis14
Corticosteroids and circadian rhythms in the cardiovascular system14
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms14
Practical application of breath tests in disorders of gut–brain interaction14
Bioprinted nanocomposite hydrogels: A proposed approach to functional restoration of skeletal muscle and vascular tissue following volumetric muscle loss14
From serendipity to rational drug design in brain disorders: in silico, in vitro, and in vivo approaches14
Optic nerve regeneration: Potential treatment approaches14
Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases14
Nonsteroidal mineralcorticoid receptor antagonists: Novel therapeutic implication in the management of patients with type 2 diabetes14
How organoids can improve personalized treatment in patients with gastro-esophageal tumors13
A computational overview on phylogenetic characterization, pathogenic mutations, and drug targets for Ebola virus disease13
RAD51 paralogs: Expanding roles in replication stress responses and repair13
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma13
Targeting the altered duodenal microenvironment in functional dyspepsia13
Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation13
Purinergic signalling in graft-versus-host disease13
Therapeutic strategies for treating juvenile idiopathic arthritis13
Corrigendum to “Metformin: Still the sweet spot for CV protection in diabetes?” [Curr Opin Pharmacol 54 (2020) 202–208]13
Light-activated receptor tyrosine kinases: Designs and applications13
Photopharmacology for vision restoration13
Remyelinating strategies: What can be learned from normal brain development13
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyond13
Analgesic potential of voltage gated sodium channel modulators for the management of pain13
Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs12
The potential role of oxytocin in addiction: What is the target process?12
Applications of chemogenetics in non-human primates12
Recent developments and strategies of Ebola virus vaccines12
Health benefits of spices in individuals with chemotherapeutic drug-induced cardiotoxicity12
Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes12
Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies12
Adenosine signaling as target in cardiovascular pharmacology12
The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions12
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells12
Hormonal drugs for the treatment of endometriosis12
Targeting fibroblast-like synoviocytes in rheumatoid arthritis12
Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries12
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis12
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options11
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”11
Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome11
Preclinical pharmacology modeling of chimeric antigen receptor T therapies11
Genetic risk scores and personalization of care in fatty liver disease11
Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury11
Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway11
Highlighting vulnerabilities in the alternative lengthening of telomeres pathway11
Towards eradication of HBV: Treatment approaches and status of clinical trials11
Drug repurposing in skeletal muscle ion channelopathies11
Biased signalling in analgesic research and development11
Therapeutic innovations for geographic atrophy: A promising horizon10
Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?10
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration10
Update on anti-fibrotic pharmacotherapies in skeletal muscle disease10
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis10
Editorial overview: Introduction to the musculoskeletal section of current opinion in pharmacology10
Dementia therapeutics and cognitive rehabilitation10
The expanding role of split protein complementation in opsin-free optogenetics10
Three-dimensional culture models to study glioblastoma — current trends and future perspectives10
Cardiac circadian rhythms in time and space: The future is in 4D10
Targeting KNDy neurons to control GnRH pulses10
Pharmacology of pannexin channels10
Novel treatments in multidrug-resistant tuberculosis9
NMR applications to GPCR recognition by peptide ligands9
Modulating regulatory T cell migration in the treatment of autoimmunity and autoinflammation9
Management of blood pressure disorders in individuals with spinal cord injury9
KRAS inhibition in metastatic colorectal cancer: An update9
Purinergic signaling pathway in severe COVID-199
Targeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease9
AI-driven GPCR analysis, engineering, and targeting9
Priming metabolism with the type 5 phosphodiesterase: the role of cGMP-hydrolyzing enzymes9
Fluorescent chemigenetic actuators and indicators for use in living animals9
Targeting the endocannabinoid system for the management of low back pain9
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications9
Editorial Board8
Eosinophilic esophagitis: New molecules, better life?8
PRRT for higher-grade neuroendocrine neoplasms: What is still acceptable?8
Reviewing the toolbox for degrader development in oncology8
Role of specific CDKs in regulating DNA damage repair responses and replication stress8
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury8
The use of hormone stimulation in male infertility8
Publisher’s Note8
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance8
The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-28
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-18
Optical control of Class A G protein-coupled receptors with photoswitchable ligands8
Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations8
Low FODMAP diet beyond IBS: Evidence for use in other conditions8
Editorial Board8
Editorial Board8
Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care8
Immune dysfunction after spinal cord injury – A review of autonomic and neuroendocrine mechanisms8
Treatment of early rheumatoid arthritis: Methotrexate and beyond8
Genome structure and genetic diversity in the Ebola virus7
Three-dimensional perspective on ryanodine receptor mutations causing skeletal and cardiac muscle-related diseases7
CFTR RNA- and DNA-based therapies7
The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy7
Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle7
MedXercise: a promising strategy to promote remyelination7
Central and peripheral mechanisms involved in the control of GnRH neuronal function by metabolic factors7
Novel treatments for dry eye syndrome7
Circadian influence on inflammatory response during cardiovascular disease7
Systemic inflammation after spinal cord injury: A review of biological evidence, related health risks, and potential therapies7
Immune tolerance therapies for autoimmune diseases: Shifting the goalpost to cure7
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus7
Effects of protein glycation and protective mechanisms against glycative stress7
Small molecule screening as an approach to encounter inefficient myelin repair7
Regulation of pathway choice in DNA repair after double-strand breaks7
Advances in tethered photopharmacology for precise optical control of signaling proteins7
Targeting ferroptosis in the maintenance of mitochondrial homeostasis in the realm of septic cardiomyopathy7
Advances in antiobesity mechanisms of capsaicin7
0.19784498214722